Host-derived Lactobacillus plantarum alleviates hyperuricemia by improving gut microbial community and hydrolase-mediated degradation of purine nucleosides
Abstract
The gut microbiota is implicated in the pathogenesis of hyperuricemia (HUA) and gout. However, it remains unclear whether probiotics residing in the host gut, such as Lactobacillus, can prevent HUA development. Herein, we isolated Lactobacillus plantarum SQ001 from the cecum of HUA geese and conducted in vitro assays on uric acid (UA) and nucleoside co-culture. Metabolomics and genome-wide analyses, revealed that this strain may promote nucleoside uptake and hydrolysis through its nucleoside hydrolase gene. The functional role of iunH gene was confirmed via heterologous expression and gene knockout studies. Oral administration of L. plantarum SQ001 resulted in increased abundance of Lactobacillus species and reduced serum UA levels. Furthermore, it downregulated hepatic xanthine oxidase, a key enzyme involved in UA synthesis, as well as renal reabsorption protein GLUT9, while enhancing the expression of renal excretion protein ABCG2. Our findings suggest that L. plantarum has potential to ameliorate gut microbial dysbiosis with HUA, thereby offering insights into its potential application as a probiotic therapy for individuals with HUA or gout.
Editor's evaluation
Multiple studies have shown that the gut microbiota is involved in the metabolism of uric acid and influences systemic uric acid levels. However, the specific bacteria and genes involved in this process are not known. The current study provides convincing evidence that Lactobacillus plantarum prevents the synthesis of uric acid through the hydrolysis of nucleosides through the nucleoside hydrolase gene (iunH). This marks a valuable contribution to the field.
https://doi.org/10.7554/eLife.100068.sa0eLife digest
Our blood contains many components, including waste products that need to be transported to the kidneys, where they can exit the body through urine. One such molecule, known as uric acid, forms when cells break down old DNA and other similar molecules. This process has several steps, with DNA being broken down into intermediate molecules called nucleosides before being converted into uric acid.
If the amount of uric acid in the bloodstream becomes too high (a condition known as hyperuricemia), humans and other animals can develop high blood pressure, chronic kidney disease and other illnesses. Recent studies suggest that some types of ‘friendly’ bacteria living in the human gut may influence how uric acid levels are regulated. But the precise role these bacteria play remains unclear.
Here, Fu, Luo et al. isolated one of these friendly bacterial species, known as Lactobacillus plantarum, from the gut of geese with hyperuricemia. The team grew the bacteria in the laboratory in two environments: one containing uric acid and the other containing nucleosides. The experiments revealed that while Lactobacillus plantarum does not directly act on uric acid, it does have enzymes that can convert nucleosides into other molecules.
Further investigations, using whole-genome and metabolomic analyses, showed that Lactobacillus plantarum contains three genes encoding enzymes that act on a type of nucleoside known as a purine. Knocking out one of these genes prevented the bacteria from being able to convert purines into other molecules. Subsequently, Fu, Luo et al. demonstrated that Lactobacillus plantarum helps to mitigate the effects of hyperuricemia in geese and mice.
These findings provide valuable insights into how microbes living in the gut regulate uric acid levels in their hosts. They may also inform future strategies for preventing and treating hyperuricemia in humans.
Introduction
Hyperuricemia (HUA) is a metabolic disorder characterized by elevated serum uric acid (UA) levels exceeding 420 μmol/l (7 mg/dl), and affecting 8–25% of the global population (Li et al., 2022). The incidence of HUA is on the rise, especially among younger populations, driven by diets high in purine and glucose. Moreover, HUA has been linked to various health risks including gout, renal injury, diabetes, hypertension, and cardiovascular disease, thereby posing a significant public health concern (Johnson et al., 2018; Zhang et al., 2019a).
The regulation of HUA primarily involves three organs: the liver, kidney, and the intestine (Dalbeth et al., 2021). The upregulation of hepatic purine metabolism and inhibition of renal UA excretion play pivotal roles in the pathogenesis of HUA, while the intestine contributes to both UA production and excretion (Dalbeth et al., 2021; Niu et al., 2018). The gut accounts for approximately one-third of total urate excretion. Upon secretion into the gut, UA undergoes metabolism by gut microbes. Therefore, dysbiosis in the gut microbiota is closely associated with dysregulation of urate degradation and systematic inflammation in the host (Yun et al., 2017). However, it remains unclear how specific gut microbes influence elevated levels of UA and inflammation in the host.
Probiotics and prebiotics have emerged as promising natural therapies due to their beneficial effects on gut microbiota regulation and overall health enhancement (Zhao et al., 2022b; Wang et al., 2022). Modulating the gut microbiota and maintaining intestinal balance through probiotics, prebiotics, and even fecal transplants may represent a novel approach to managing HUA from a microecological perspective. Lactobacillus is a well-known probiotic that has been reported to utilized for modulating the gut microbiota and alleviating HUA (Cao et al., 2022a). Previous studies have demonstrated two mechanisms involved in the alleviation of HUA by Lactobacillus. The first one is directly degrading UA (Wu et al., 2021), and the other is degrading nucleosides, the precursors of UA in the gut (Cao et al., 2022b; Li et al., 2014; Hsu et al., 2019). However, the specific mechanisms by which these Lactobacillus spp. degrade UA or nucleosides remain incompletely understood. Recent investigations have indicated that ribonucleoside hydrolase RihA-C and the nucleoside hydrolase Nhy69 from Lactobacillus, which cloned and recombinant, shed light on a potential degradation mechanism within Lactobacillus (Li et al., 2023a; Li et al., 2023b). Nevertheless, there is limited evidence regarding gene knockout validation in Lactobacillus and the alleviation of host-derived Lactobacillus in HUA is still unknown.
The establishment of reliable and stable animal models for HUA has been a subject of debate among researchers. Mouse models are extensively utilized in HUA or gout studies, but they pose certain challenges as previous studies described. In addition to variances in uricase activity and urate concentration, the mouse modeling form also varies from the development of HUA in humans (Lu et al., 2019). Prior research has demonstrated that geese serve as an excellent model for investigating HUA and gout (Wang et al., 2021; Fu et al., 2024; Xi et al., 2019; Dalbeth et al., 2016).
Here, we established an HCP (High calcium and protein) diet-induced HUA geese model, and isolated a Lactobacillus plantarum strain, SQ001, from HUA geese. Its nucleoside degradation function was investigated through in vitro experiments compared to commercial strains. Genome-wide analysis revealed four genes (iunH, yxjA, rihA, and rihC) in L. plantarum SQ001 that potentially contribute to nucleoside degradation. We subsequently confirmed the nucleosides hydrolase function of iunH through heterologous expression in E. coli and gene knockout in L. plantarum SQ001. Oral gavage of L. plantarum SQ001 further validated the alleviating effect of L. plantarum SQ001 in the HUA geese and mouse model. In conclusion, our findings demonstrated that host-derived gut microbes could alleviate gut microbial dysbiosis and HUA in hosts, and provided insights into the potential therapeutic use of L. plantarum for improving HUA or gout.
Results
Gut microbiota differences in diet-dependent HUA
To investigate the potential effects of gut microbiota, geese were assigned to either a normal or HCP diet and maintained on their respective diets for 28 consecutive days (Figure 1a), food recipes and nutrient levels of experimental diets refer to our previous article (Fu et al., 2024). In geese fed the HCP diet for 28 days, markedly worsened growth performance was shown by lower final average weight (p < 0.0001), higher mortality (p < 0.0001), and higher relative weight of liver (p = 0.0254; Figure 1b–d). Moreover, the serum biochemical results indicated the successful construction of the HUA model. Serum UA (p < 0.0001), xanthine oxidase (XOD; p < 0.0001), blood urea nitrogen (BUN; p < 0.0001), and creatinine (p < 0.0001) were significantly elevated in the HUA group, with UA exceeding the threshold (420 μmol l−1; Figure 1e, f).
To investigate the impact of dietary patterns on gut microbiome remodeling, 16S ribosomal RNA (rRNA) gene sequencing of cecal chyme from CON and HUA geese was conducted after 28 days. The HCP diet caused a slight but significant decrease in the alpha diversity of gut microbiota in geese (Chao index, p = 0.0027; Shannon index, p = 0.0100; Figure 2a, b). Analysis of beta diversity using the Bray–Curtis dissimilarity metric in principal coordinate analysis (PCoA) showed a clear segregation of gut microbial signatures between CON and HUA groups (p = 0.0040; Figure 2c). LDA (linear discriminant analysis) effect size (LEfSe) analysis of the taxonomic changes revealed that the HCP diet led to distinct bacterial enrichment. The main bacterial families present in geese on a normal diet were Butyricicoccaceae (p = 0.0003), Ruminococcaceae (p = 0.0103), and Lactobacillaceae (p = 0.0003). Conversely, the species Ruminococcus torques group (p < 0.0001) and Ruminococcus gauvreauil group (p = 0.0005) showed significant proliferation when geese were fed an HCP diet (Figure 2d, e and Figure 2—figure supplement 1A–C).
These findings collectively indicate a significant impact of the HCP diet on gut microbial remodeling, particularly reflected in the changes in Lactobacillus and Butyricicoccus abundances. Furthermore, based on Phylogenetic Investigation of Communities by Reconstruction of Unobserved States (PICRUSt) prediction analysis, the abundance profile of the Kyoto encyclopedia of genes and genomes (KEGG) pathway revealed that purine metabolism (p = 0.0002) and Mitogen-activated protein kinase (MAPK) signaling pathway (p = 0.0218) in gut microbiota has increased significantly, while alpha-linolenic acid metabolism has decreased considerably (Figure 2f). The overall findings of this study suggested that HUA in geese has a detrimental impact and leads to alterations in the composition of gut microbiota.
L. plantarum SQ001 hydrolyze nucleosides in vitro
We acquired a strain, L. plantarum SQ001, from a cecal chyme sample collected from HUA geese. Whole-genome sequencing of L. plantarum SQ001 was performed and a completed genome was obtained. Comparing it with the 18 strains from the RefSeq, L. plantarum SQ001 was closer to L. plantarum A (GCF_000463075.2, 0.866) (Figure 3a). Scanning electron microscopy showed it to be long rod-shaped (Figure 3b). To elucidating the mechanism by which L. plantarum SQ001-mediated alleviation in HUA, the ability of L. plantarum SQ001 to metabolize UA was initially investigated. L. plantarum SQ001 has no effect on the degradation of UA (Figure 3c, d), but it can metabolize purine nucleosides (inosine and guanosine), the precursors of UA production. Results indicated that L. plantarum SQ001 completely absorbed or hydrolyzed both purine nucleosides within 6 hr (p < 0.0001; Figure 3e, f). These findings indicated that L. plantarum SQ001 alleviates HUA not through direct degradation of UA, but by metabolizing its precursors.
Purine metabolism of L. plantarum SQ001 was activated by nucleosides
Although it is clear that L. plantarum SQ001 is involved in nucleoside degradation, the specific metabolic impact on L. plantarum SQ001 is unclear. Further, after 6 hr of co-culture with nucleoside solutions (inosine, adenosine, and guanosine), principal component analysis (PCA) and volcano plots revealed that L. plantarum SQ001 has modified the composition of nucleoside solutions and reduced the amount of inosine present (Figure 4a–c). KEGG analysis revealed the enrichment of metabolites in the purine metabolism pathway (Figure 4d). Heatmaps of differential metabolites revealed that L. plantarum SQ001 significantly reduced levels of inosine (p < 0.0001), guanosine (p < 0.0001), and adenosine (p < 0.0001), while elevating levels of guanine (p < 0.0001), xanthine (p < 0.0001), and proline (p < 0.0001; Figure 4e).
We further examined the intracellular metabolic changes in L. plantarum SQ001, both with and without incubation with nucleosides (inosine, adenosine, and guanosine). PCA and volcano plots showed that the nucleoside solution altered the intracellular metabolite composition of L. plantarum SQ001, with an increase in the content of inosine (Figure 4f, g). KEGG analysis indicated a notable enrichment of metabolites in the purine metabolism pathway (Figure 4h). Heatmaps illustrating the differences in metabolite levels demonstrated a significant increase in inosine (p < 0.0001), guanosine (p < 0.0001), adenosine (p < 0.0001), guanine (p < 0.0001), xanthine (p < 0.0001), and adenine (p = 0.0025), while alpha-linolenic acid (p = 0.0018) and proline (p < 0.0001) levels showed a significant decrease (Figure 4i).
Overall, we have confirmed the absorption and hydrolysis of nucleosides by L. plantarum SQ001. Moreover, we have identified several potentially advantageous metabolites, such as linolenic acid and proline that are synthesized. However, the exact mechanism by which L. plantarum SQ001 absorbs and hydrolyze nucleosides is unclear.
L. plantarum SQ001 hydrolyze nucleosides through nucleoside hydrolase, which has the potential to alleviate HUA
The genome consisted of 3,549,454 bp and was predicted to contain 3361 coding sequences (CDSs) and 85 RNA genes (Figure 5a). A total of 2,739 protein-coding genes in the genome of L. plantarum SQ001 were annotated using clusters of orthologous groups (COG). Among these, genes with unknown functions (S) comprised the largest proportion (19.51%), followed by genes involved in (G) carbohydrate transport and metabolism, (E) amino acid transport and metabolism, and (F) nucleotide transport and metabolism (Figure 5b).
In the nucleotide transport and metabolism category, the genome of L. plantarum SQ001 contained 89 protein-coding genes. Two genes were identified as nucleoside hydrolases (iunH), two as ribonucleoside hydrolases (rihA, rihC), and one as a nucleoside permease (yxjA) (Figure 5c). These genes may be associated with the alleviation of HUA by L. plantarum SQ001. However, the role of L. plantarum SQ001 in HUA should be further clarified.
Here, we focused on the role of nucleoside hydrolase (iunH) in the degradation of nucleosides by L. plantarum SQ001. We first determined the role of iunH by heterologous expression, and E. coli completely degraded inosine and guanosine after 3 hr following heterologous expression of iunH (Figure 5d, e and Figure 5—figure supplement 1A, B). We further confirmed through knockout experiments that L. plantarum SQ001 exhibited a 50% reduction in nucleoside degradation upon iunH gene knockout (Figure 5f, g and Figure 5—figure supplement 1C–F).
Overall, we demonstrated that L. plantarum SQ001 hydrolyze nucleosides through nucleoside hydrolase iunH. However, the mitigating effect of L. plantarum SQ001 on hyperuricemic geese remains to be verified.
L. plantarum SQ001 and L. plantarum SQ001 with metabolites alleviate HCP diet-induced HUA
To further confirm the functional role of L. plantarum SQ001 in HUA, we administered L. plantarum SQ001 and L. plantarum SQ001 with metabolites to HUA geese via oral gavage for 14 days, respectively (Figure 6a). The results showed a markedly improved growth performance, as shown by improved final average weight (p < 0.0001; Figure 6b), and decreased mortality (p = 0.0003; Figure 6c), relative weight of liver (p = 0.0800) and kidney (p = 0.0200; Figure 6d). Additionally, both L. plantarum SQ001 and L. plantarum SQ001 with metabolites significantly reduced serum UA (p < 0.0001), XOD (p < 0.0001), BUN (p < 0.0001), and creatinine contents (p < 0.0001), and decreased serum Interleukin-1β (IL-1β, p < 0.0001), Tumor necrosis factor-α (TNF-α, p < 0.0001), and Interferon-γ (IFN-γ, p < 0.0001) levels (Figure 6e–g). Geese oral with the L. plantarum SQ001 and L. plantarum SQ001 with metabolites showed attenuated jejunum phenotypes damage including villus length (p = 0.0051), and crypt depth (p = 0.0122; Figure 7a, b). In addition, L. plantarum SQ001 relieved pathological injuries such as inflammatory cell infiltration in the liver and kidney as reflected by the pathological sections (p < 0.0001; Figure 7c, d). These findings demonstrate the alleviation of HUA in geese by L. plantarum SQ001, but the role played by gut microbes is unclear.
Sequencing analysis of cecal chyme revealed that both L. plantarum SQ001 and L. plantarum SQ001 with metabolites significantly increased microbiota richness (Chao index, p < 0.0001) and uniformity (Shannon index, p < 0.0001) compared to the HUA group (Figure 8a and Figure 8—figure supplement 1A). PCoA analysis showed the separation of gut microbiota in L. plantarum SQ001, L. plantarum SQ001 with metabolites, and HUA groups (Figure 8b). Sequencing results showed that L. plantarum SQ001 and L. plantarum SQ001 with metabolites significantly enhanced the relative abundance of phylum Firmicutes (Figure 8—figure supplement 1B), family Lachnospiraceae (p = 0.0218), family Ruminococcaceae (p = 0.0049; Figure 8c), family Lactobacillaceae (p = 0.0005; Figure 8d), and family Butyricicoccaceae (p = 0.0278; Figure 8e and Figure 8—figure supplement 1C). Meanwhile, the relative abundance of genus Lactiplantibacillus (p = 0.0012), Butyricicoccus (p = 0.0350), and species L. plantarum (p = 0.0003), B. pullicaecorum (p = 0.0059) were also markedly boosted (Figure 8d, e and Figure 8—figure supplement 1D). Overall, L. plantarum SQ001 ameliorated HCP diet-induced gut microbiological disturbances, restored and increased the abundance of Lactobacillus spp. and Butyricicoccus spp. and ultimately alleviated HUA in geese.
L. plantarum SQ001 alleviates HUA in a mice model
To further explore the role of L. plantarum SQ001 in alleviating HUA, Kunming mice were utilized as an additional HUA model, and oral gavage of L. plantarum SQ001 was administered (Figure 9a). L. plantarum SQ001 significantly reduced knee joint thickness (p = 0.0011; Figure 9b), relative kidney weight (p = 0.0038; Figure 9c), serum UA levels (p = 0.0022), and serum XOD activity (p = 0.0348) in the HUA model mice (Figure 9d). Further analysis of key hepatic enzymes involved in UA formation revealed that L. plantarum SQ001 significantly lowered the expression of phosphoribosyl pyrophosphate synthetase (PRPS, p = 0.0044) and xanthine oxidase (XO, p < 0.0001; Figure 9e) in the liver. Additionally, L. plantarum SQ001 reduced the protein expression associated with UA reabsorption in the kidneys, including glucose transporter 9 (GLUT9, p = 0.0085), and increased the expression of the urate excretion protein ATP-binding cassette transporter G2 (ABCG2, p = 0.1028; Figure 9f). Collectively, these findings suggest that L. plantarum SQ001 can alleviate HUA, primarily by decreasing UA production in the liver and enhancing UA excretion in the kidneys.
To further confirm the HUA-alleviating effect of L. plantarum SQ001, we performed an untargeted metabolomic analysis of serum metabolites. PCA demonstrated that the two groups exhibited distinct metabolite profiles (Figure 10a, b). Pathway enrichment analysis revealed that the identified metabolites were predominantly linked to purine metabolism (Figure 10c, d). L. plantarum SQ001 decreased the levels of inosine and xanthosine, and significantly increased the L-proline, L-valine, L-arginine, L-targinine, and L-methionine levels (Figure 10e). Further investigation of the gut microbiota showed that L. plantarum SQ001 significantly increased the Chao (p < 0.0001) and Shannon indices (p = 0.0002; Figure 10f). PCA revealed distinct differences in the gut microbiota among the four groups (Figure 10g). Operational taxonomic unit species composition analysis revealed that L. plantarum SQ001 restored the ratio of Fimicutes to Bacteroidota, increased the abundance of Lactobacillaceae, Lactobacillus, Lactobacillus murinus, and Lactobacillus reuteri, and decreased the abundance of Staphylococcus and Staphylococcus xylosus (Figure 10h–k). Moreover, L. plantarum SQ001 increased the abundance of L. plantarum (Figure 10l). Additionally, Spearman correlation analysis showed that Lactobacillus (p = 0.0360) and L. plantarum (p = 0.0120) had a significantly negative association with serum inosine level, while Bacteroides showed a substantially positive correlation with inosine (p = 0.0070; Figure 10m). Furthermore, the analysis indicated that Lactobacillus and L. plantarum had a substantially positive correlation with serum indole-3-carboxylic acid (ICA) level, while Bacteroides exhibited a significantly negative correlation with ICA.
Overall, these results demonstrated that L. plantarum SQ001 regulates hepatic and renal UA metabolism by increasing the abundance of beneficial gut bacteria, such as Lactobacillus, and reducing the levels of UA precursors.
Discussion
Gut microbial disorders may be strongly associated with the formation of HUA induced by high purine diets. In our study, we observed a significant decrease in the abundance of Lactobacillus, L. plantarum, Butyricicoccus, and B. pullicaecorum in the cecum of HUA geese, and a significant increase in the abundance of R. torques and R. gauvreauil groups. L. plantarum SQ001, derived from HUA model geese, showed nucleoside degradation function through an in vitro assay. Following oral gavage in HUA geese significantly reduced serum UA levels and alleviated hepatic and renal inflammation, simultaneously restoring intestinal microbial disorders. In addition, oral gavage of L. plantarum SQ001 to an HUA mouse model similarly increased Lactobacillus and L. plantarum abundance, and reduced the serum UA level (Figure 11). These results suggested that host-derived beneficial bacteria, L. plantarum, improved the intestinal flora and alleviated the HUA in host.
The low abundance of Lactobacillus spp. and Butyricicoccus spp. suggests a possible antagonistic role in the development of HUA. Studies have shown that oral administration of Lactobacillus spp. such as L. plantarum, Lactobacillus rhamnosus, and Limosilactobacillus could maintain gut microbiota balance, increase the abundance of Lactobacillus, and reduce serum UA levels (Wang et al., 2022; Cao et al., 2022a; Zhao et al., 2022a). Our findings also showed that L. plantarum SQ001 ameliorated the intestinal microbiota disturbance and serum UA elevation, and restored the Firmicutes to Bacteroidetes ratio, which are associated with metabolic diseases. In HUA mouse model, L. plantarum SQ001 reduced the expression of hepatic UA synthesis proteins PRPS, XO, and renal UA reabsorption protein GLUT9, while increasing the expression of renal UA excretory protein ABCG2. In a healthy body, UA levels are regulated by a delicate balance between its production and excretion. Excessive production or insufficient excretion of UA can lead to the development of HUA (Li et al., 2023b). The enzymes PRPS and XO are crucial for UA synthesis, catalyzing its production. GLUT9 is located on the apical brush-border membrane (urine side) of renal proximal tubules and functions as a UA reabsorption transporter. Conversely, ABCG2 is primarily found on the basolateral (blood-side) membrane of proximal tubule cells in the kidney, facilitating the outward excretion of UA from the renal tubules. The downregulation of GLUT9 expression and the upregulation of ABCG2 expression facilitate increased UA excretion, thereby reducing serum UA accumulation (Dalbeth et al., 2021).
In this study, L. plantarum SQ001 further reduced the expression of the pro-inflammatory cytokine IL-1β in serum. Meanwhile, liver and kidney inflammation in HUA geese were alleviated. However, the mechanism by which L. plantarum SQ001 alleviated inflammation has not been elucidated. Studies have shown that L. plantarum could alleviate inflammation by promoting short-chain fatty acids (SCFAs) production and the abundance of SCFA-producing beneficial bacteria (Chien et al., 2022; Wei et al., 2021). Butyricicoccus and B. pullicaecorum have been reported to enhance intestinal barrier function and inhibit inflammation by improving butyrate production, which indicated the probable underlying mechanism (Marteau, 2013; Devriese et al., 2017). We observed that L. plantarum SQ001 enhanced the abundance of Lactobacillus, L. plantarum, Butyricicoccus, and B. pullicaecorum in the gut, improved intestinal villus morphology and restored the intestinal barrier. R. torques group has been associated with the development of gastrointestinal disorders, and its abundance was significantly increased in patients with Crohn’s disease and inflammatory bowel disease (Joossens et al., 2010; Henke et al., 2019). R. gauvreauil group is associated with low gut microbial abundance and its abundance is higher in patients with atherosclerotic cardiovascular disease (Henke et al., 2019). However, there is insufficient evidence for a causal relationship between R. torques group, R. gauvreauil group, and the development of HUA. Our results suggested that L. plantarum SQ001 reversed the HCP diet-induced increase in abundance of R. torques and R. gauvreauil groups. In addition, in the HUA mouse model, L. plantarum SQ001 increased the abundance of Lactobacillaceae, Lactobacillus, L. murinus, and L. reuteri, while decreasing the abundance of Staphylococcus and S. xylosus. S. xylosus is a commensal pathogen on the skin and is one of the causative agents of skin inflammation, but the role of S. xylosus in the gut is unclear (Kim et al., 2017). The findings also indicated a robust positive correlation between Lactobacillus, especially L. plantarum, and the serum ICA levels. Research has demonstrated that toxins are metabolized by enzymes like Cytochrome P450 2E1 (CYP2E1) and converted into reactive species, causing oxidative damage and liver failure. ICA binds to and deactivates CYP2E1, thereby inhibiting the formation of harmful reactive intermediates and reducing oxidative damage to hepatocytes (Li et al., 2024). Moreover, L. gallinarum-derived ICA suppressed colorectal cancer by inhibiting CD4+ Treg differentiation and enhancing CD8+ T cell function (Fong et al., 2023). However, the mitigating effects and mechanisms of ICA in HUA need further validation. In conclusion, L. plantarum SQ001 improved the intestinal microbiota disorders, increased the abundance of beneficial bacteria, and alleviated HUA. Impressively, Spearman correlation analysis revealed a significant negative association between inosine and both Lactobacillus and L. plantarum in terms of serum metabolites and gut microbes. Lactobacillus and L. plantarum may work by hydrolyzing inosine.
Previous studies have shown that some Lactobacillus can alleviate HUA. The strain Limosilactobacillus fermentum JL-3, isolated from Chinese slurry water, degraded UA and alleviated HUA, but the specific UA-lowering mechanism has not been elucidated (Cao et al., 2022b). Apart from hydrolyzing UA, Lactobacillus spp. from various sources could lower serum UA levels by hydrolyzing nucleosides. For instance, Lactobacillus paracasei X11 and L. plantarum DM9218-A, isolated from Chinese sauerkraut, and L. plantarum GKM3, isolated from Chinese mustard, have shown this capability (Li et al., 2014; Hsu et al., 2019; Li et al., 2023a; Li et al., 2023b). However, the mechanism by which these Lactobacillus spp. degrade nucleosides has not yet been fully understood. Recent studies have shown that L. plantarum from Chinese sauerkraut and Lactobacillus aviarius from chicken cecum contents are capable of degrading nucleosides, and the possible degradation mechanism was elucidated by gene cloning and recombination to obtain ribonucleoside hydrolase RihA-C and nucleoside hydrolase Nhy69 (Li et al., 2023a; Li et al., 2023b). Even though the validation of degradation function in bacteria has been investigated in these studies, functional verification on the deficiency of critical genes in strains has not been elucidated. Additionally, the investigation of host-derived and repurposed Lactobacillus strains with HUA-relieving properties remains unexplored, while these particular Lactobacillus strains often exhibit antagonistic effects within the host suffering from HUA. Our results showed that L. plantarum SQ001 contains four nucleoside hydrolysis-related enzymes (iunH, yxjA, rihA, and rihC), and suggested that nucleoside hydrolase iunH is involved in nucleosides (inosine and guanosine) degradation. Metabolomics showed that nucleosides were efficiently converted to nucleobases in this assay. Although a direct link between nucleobase transport and host urate levels has not yet been established, the absence of nucleobase transport proteins in intestinal epithelial cells may be necessary for reducing their uptake and metabolism of urate production, resulting in a reduction in host serum urate. Moreover, changes in intracellular and extracellular ectonucleoside levels, which may reveal a role for nucleoside transporter-related enzymes, such as yxjA, but further validation is needed. Metabolomics indicated an increase in linolenic acid and proline after co-culture with nucleosides. Studies suggest that consuming linolenic acid-rich foods is linked to a reduced risk of gout recurrence, and alpha-linolenic acid inhibits the URAT1 protein, which reabsorbs UA in the kidneys (Zhang et al., 2019b; Saito et al., 2020). Additionally, microbial-derived proline enhances UA excretion in the intestines and kidneys, helping to alleviate HUA (Fu et al., 2024).
In conclusion, our study investigated the changes in gut microbes of HUA geese and mouse, and found the critical genes with nucleoside hydrolysis function in host-derived L. plantarum strain, finally demonstrating its purine nucleoside hydrolysis function in vitro and in vivo experiments. This study is expected to contribute insight into HUA metabolism and provide new strategies for HUA or gout therapy via host-derived gut microbe.
Materials and methods
Animal management
Request a detailed protocolThe experimental procedure followed was identical to that previously outlined (Fu et al., 2024). Healthy 1-day-old male geese were obtained from Shixing (Guangdong China). These geese were kept in stainless steel cages, with five geese per cage, and were provided with unlimited access to food and water. The environment was carefully controlled, starting with a temperature of 33 ± 1°C, which was reduced by 2.5 ± 0.5°C weekly until it stabilized at 26°C. Relative humidity levels were maintained between 45% and 60%.
HUA modeling treatment
Request a detailed protocolThe experimental procedure adhered to the methodology described previously (Fu et al., 2024). Eighty one-day-old male geese were randomly assigned to two groups: the control (CON) and the HUA groups. From day 1 to 28, the dietary formulations and nutrient levels followed our prior publication (Fu et al., 2024). The CON group was provided with a standard diet, while the HUA group received an HCP diet.
LP and LP with metabolite gavage treatment in an HUA goose model
Request a detailed protocolThe experimental procedure adhered to the same methodology as previously described (Fu et al., 2024). 120 1-day-old male geese were selected and assigned to two groups: the CON group (A) and the HUA group (B). After 14 days of HUA modeling treatment, the HUA group was further assigned to three subgroups (B, C, and D). From day 14 to 28, A and B received phosphate-buffered saline (PBS), C received LP bacteria resuspended in PBS, and D received LP with metabolites (containing LP at a concentration >1 × 1010 CFU). One goose from each replicate in all groups was slaughtered for analysis at 28 days.
Intraperitoneal injection and gavage in mice
Request a detailed protocolThe experimental procedure adhered to the methodology described previously (Li et al., 2023b). Thirty-two male Kunming mice (25 ± 2 g), aged 5 weeks, were acquired from the Guangdong Provincial Medical Laboratory Animal Center, Guangdong, China, and housed in an SPF (specific pathogen-free) facility at the Laboratory Animal Center, South China Agricultural University. The mice were kept in stainless steel cages, with each cage housing up to four mice, and provided with sterile food and water ad libitum. The environment was maintained at a constant temperature of 25 ± 1°C with a 12-hr light/dark cycle. A 5-day acclimatization period was observed to allow the mice to adapt to the conditions. All mice received a consistent maintenance diet throughout the study. The 32 mice were divided into four groups based on body weight. The model group (HUA) was administered hypoxanthine (100 mg/kg) orally and potassium oxonate (300 mg/kg) intraperitoneally daily, both dissolved in a 5% sodium carboxymethylcellulose solution. The gavage group received either 39 mg/ml AL (AL group) or 0.2 ml of a fresh bacterial solution (LP group, 1 × 1010 CFU/ml) daily, in addition to the modeling treatment. The control group (CON) was given the same dose of sodium carboxymethylcellulose, and both the control and model groups received PBS by gavage. The experiment spanned 19 days, with knee joint thickness measured using vernier calipers on the final day. All mice were humanely euthanized by CO2 overdose followed by cervical dislocation, in accordance with ethical guidelines.
Sample collection
Request a detailed protocolThe experimental procedure followed the same methodology as previously described (Fu et al., 2024). Blood samples were collected from each individual, and serum was separated by centrifugation (1200 × g, 10 min, 4°C), then stored at −30°C for analysis. The entire heart, liver, kidney, spleen, thymus, pancreas, bursa of Fabricius, muscular stomach, and glandular stomach were collected and weighed. The lengths of the duodenum, jejunum, ileum, and cecum were measured. Liver, kidney, and jejunum (approximately 1–2 cm) were obtained after rinsing with PBS. Cecum and colon chyme were collected and stored at −80°C until further analysis. Animal body weights were monitored regularly throughout the treatment period.
Analysis of biochemical parameters
Request a detailed protocolThe experimental procedure adhered to the same methodology as previously described (Fu et al., 2024). Serum UA, XOD, BUN, creatinine, calcium, and phosphorus (P) were measured by biochemical kits, all kits were purchased from Jiancheng (Nanjing, China). IL-1β, TNF-α, and IFN-γ levels were measured by Enzyme-Linked Immunosorbent assay (ELISA) kit (Meimian Industrial, Jiangsu, China) according to the manufacturer’s protocol.
Western blot analysis
Request a detailed protocolTotal protein was extracted by RIPA (Sigma‐Aldrich) buffer supplemented with protease and phosphatase inhibitors and protein concentration was determined by a BCA Assay Kit (Thermo Fisher Scientific, USA). Equal protein amounts (20 μg) were electrophoresed on 10% sodium dodecyl sulfate–polyacrylamide gel and the separated proteins were transferred onto the polyvinylidene difluoride (PVDF) membranes (Amersham International, GE Healthcare). The membranes were blocked with Tris-buffered saline with Tween (TBST) containing 3% bovine serum albumin (BSA) for 1 hr at room temperature, and then overnight in primary antibody (Supplementary file 1) at 4°C. After several times washes in TBST, the membranes were incubated with secondary antibodies in TBST containing 3% BSA for 1 hr at room temperature. Subsequently, the membranes were treated with ECL western blotting substrate (Amersham International, GE Healthcare, Chicago, IL, USA) and imaged using a chemiluminescence detection system (Bio-Rad Laboratories, Hercules, CA, USA). The band intensity was quantified using ImageJ software.
16S rRNA sequencing
Request a detailed protocolThe experimental procedure followed the same methodology as previously described (Fu et al., 2024). Microbial genomic DNA from cecal contents was subjected to 16S rRNA gene sequencing according to the standard protocols of Majorbio (Shanghai, China). The SILVA database was employed to categorize amplicon sequence variants. Alpha diversity was evaluated for each sample to determine bacterial abundance and uniformity. Differences in gut microbial community structure between groups were analyzed using Unifrac-based weighted PCoA, and statistical differences between groups were assessed with ANOSIM analysis. The nonparametric factorial Kruskal–Wallis and rank tests were used to identify bacterial species with statistically significant differences. Subsequently, LDA scores in LEfSe analyses were utilized to estimate the impact of species abundance on these differences. Correlation coefficients between bacterial species and serum metabolomics were calculated using Spearman correlation analysis. Functional pathways predicted by 16S rRNA data were illustrated using PICRUSt software.
Strains and Media
Request a detailed protocolThe experimental procedure followed the same methodology as previously described (Fu et al., 2024). The L. plantarum strain SQ001 (CGMCC NO 24791) and the standard E. coli strain were obtained from the Waterfowl Nutrition Laboratory (South China Agricultural University, Guangdong, China). LB (Luria-Bertani) and MRS (deMan Rogosa Sharpe) media were procured from Huankai (Guangdong, China). Following the collection of cecal chyme, the suspension was cultured across nine gradient dilutions in a clean bench. Single colonies were then picked, cultured in liquid medium, followed by DNA extraction for 16S rRNA sequencing, with strain identification through NCBI comparisons. E. coli was cultured in LB liquid medium, while L. plantarum was cultured in MRS liquid medium, both incubated at 37°C for 12 hr. A 5% inoculum volume (vol/vol) was introduced and cultured for three consecutive generations. Subsequently, a 10% inoculum volume (vol/vol) was transferred to the medium for further experiments.
Determination of UA degradation rate
Request a detailed protocolThe experimental procedure followed the same methodology as previously described (Fu et al., 2024). The UA solution was prepared by dissolving 40 mg of UA (0.4 g/l) in 100 mL of K3PO4 solution (10 mmol/l, pH 7.0). A standard curve (0.4, 0.2, 0.1, 0.05, and 0.025 g/l; concentration–peak area) was generated using the external standard method. Next, 2 ml of a 20-hr bacterial culture was centrifuged (n = 3, 6000 × g, 4°C, 10 min). The pellet underwent two washes with 1 ml of sterile PBS before being resuspended in 750 μl of UA solution. This mixture was incubated for 24 hr (n = 3, 37°C, 120 r/min).
Determination of nucleoside degradation rate
Request a detailed protocolThe experimental procedure followed the same methodology as previously described (Fu et al., 2024). A nucleoside solution was prepared by dissolving 20 mg of inosine (0.2 g/l) and 20 mg of guanosine (0.2 g/l) in 100 ml of K3PO4 solution (10 mmol/l, pH 7.0). A standard curve (0.2, 0.1, 0.05, 0.025, and 0.0125 g/l; concentration–peak area) was established using the external standard method. Subsequently, 2 ml of a 20-hr bacterial culture was centrifuged (n = 3, 6000 × g, 4°C, 10 min). The pellet underwent two washes with 1 ml of sterile PBS before being resuspended in 750 μl of nucleoside solution and incubated for 1, 3, and 6 hr (n = 3, 37°C, 120 r/min).
High-performance liquid chromatography determination
Request a detailed protocolThe experimental procedure followed the same methodology as previously described (Fu et al., 2024). The solution was centrifuged (4000 × g, 4°C, 10 min). Then, 720 μl of the supernatant was mixed with 80 μl of HClO4 (9:1, 0.1 mol/l). After filtering through a membrane (0.22 μm), 20 μl of the mixture was injected into a high-performance liquid chromatography (HPLC) system. The HPLC utilized a C18 reversed-phase column (spursil EP, 250 mm × 4.6 mm, 5 μm). The mobile phase comprised 20 mmol/l potassium dihydrogen phosphate solution (pH 3.0) with 1% methanol. The flow rate was set to 1 ml/min, and the column temperature was maintained at 25°C. The detection wavelength was 254 nm, and the elution time was 30 min.
Heterologous expression and gene knockout
Request a detailed protocolOligonucleotide primers were synthesized by DynaScience (Qingdao, China), and sequencing services were provided by Huada (Shenzhen, China). The heterologous expression plasmid p15A-cm-Pgenta-iunH and the gene knockout plasmid p15A-cm-HA-G-iunH-erm-sacB were prepared as previously described (Fu et al., 2024). All strains, plasmids, mutants, and primers used in this study are detailed in Supplementary file 1.
Untargeted metabolomics analysis
Request a detailed protocolThe experimental procedure adhered to the same methodology as previously described (Fu et al., 2024). Metabolites were extracted using an extraction solution composed of methanol, acetonitrile, and water in a 2:2:1 ratio (500 μl total volume), incorporating an isotope-labeled internal standard mixture. The supernatant obtained was used for LC–MS/MS analysis. These analyses were performed with a UHPLC system (Vanquish, Thermo Fisher Scientific) coupled with a UPLC BEH Amide column (2.1 mm × 100 mm, 1.7 μm) and a Q Exactive HFX mass spectrometer (Orbitrap MS, Thermo). The mobile phases used were 25 mmol/l ammonium acetate and 25 mmol/l ammonium hydroxide solution (pH 9.75, A) and acetonitrile (B). The QE HFX mass spectrometer operated in information-dependent acquisition mode, managed by Xcalibur software (Thermo). Raw data were converted to mzXML format using ProteoWizard and analyzed with XCMS for peak detection, extraction, alignment, and integration. Metabolite annotation was subsequently performed using an MS2 database (Biotree, Shanghai, China) with a cutoff annotation threshold of 0.3.
Statistical analysis
Request a detailed protocolUnless otherwise specified, all data are presented as mean ± standard error of the mean. Statistical analyses were conducted using SAS 9.2 (SAS Inst. Inc, Cary, NC). Comparisons between two groups were made using the unpaired Student’s t-test or Mann–Whitney U test, while one-way ANOVA with Bonferroni’s multiple comparisons test was used for comparisons among more than two groups. p values were indicated in the figures as follows: not significant [ns], p < 0.05; *, p < 0.05; **, p < 0.01; ***, p < 0.001; ****, p < 0.0001.
Data availability
RNAseq data are available from the NCBI SRA database under the accession number PRJNA1138299 (https://www.ncbi.nlm.nih.gov/sra/PRJNA1138299). Raw data for mice serum metabolomics, L. plantarum metabolomics, and all figures are presented in Dryad (https://doi.org/10.5061/dryad.573n5tbhh).
-
Dryad Digital RepositoryHost-derived Lactobacillus plantarum alleviates hyperuricemia by improving gut microbial community and hydrolase-mediated degradation of purine nucleosides.https://doi.org/10.5061/dryad.573n5tbhh
References
-
Lactobacillus paracasei X11 ameliorates hyperuricemia and modulates gut microbiota in miceFrontiers in Immunology 13:940228.https://doi.org/10.3389/fimmu.2022.940228
-
Lactobacillus rhamnosus GG ameliorates hyperuricemia in a novel modelNPJ Biofilms and Microbiomes 10:25.https://doi.org/10.1038/s41522-024-00486-9
-
Antiobesity and uric acid-lowering effect of Lactobacillus plantarum GKM3 in high-fat-diet-induced obese ratsJournal of the American College of Nutrition 38:623–632.https://doi.org/10.1080/07315724.2019.1571454
-
Familial aggregation and antimicrobial response dose-dependently affect the risk for Crohn’s diseaseInflammatory Bowel Diseases 16:58–67.https://doi.org/10.1002/ibd.20985
-
Mouse models for human hyperuricaemia: a critical reviewNature Reviews. Rheumatology 15:413–426.https://doi.org/10.1038/s41584-019-0222-x
-
Inhibition of 3,5,2’,4’-tetrahydroxychalcone on production of uric acid in hypoxanthine-induced hyperuricemic miceBiological & Pharmaceutical Bulletin 41:99–105.https://doi.org/10.1248/bpb.b17-00655
-
The gut microbiota as a target to control hyperuricemia pathogenesis: Potential mechanisms and therapeutic strategiesCritical Reviews in Food Science and Nutrition 62:3979–3989.https://doi.org/10.1080/10408398.2021.1874287
-
Hyperuricemia and cardiovascular diseaseCurrent Pharmaceutical Design 25:700–709.https://doi.org/10.2174/1381612825666190408122557
-
Effect of dietary and supplemental omega-3 polyunsaturated fatty acids on risk of recurrent gout flaresArthritis & Rheumatology 71:1580–1586.https://doi.org/10.1002/art.40896
-
The potential of probiotics in the amelioration of hyperuricemiaFood & Function 13:2394–2414.https://doi.org/10.1039/D1FO03206B
Article and author information
Author details
Funding
National Science Fund for Outsanding Young Scholars (32222080)
- Wence Wang
Guangdong Province Natural Science Funds for Distinguished Young Scholar (2022B1515020016)
- Wence Wang
National Science Fund Project of China (32072751)
- Wence Wang
Guangdong Basic and Applied Basic Research Foundation (2022B1515130003)
- Wence Wang
Guangdong Chimelong Philanthropic Foundation (CLPF2021007Z)
- Wence Wang
China Agricultural Research System (CARS-42-15)
- Wence Wang
National Key Research and Development Program (2023YFD1301000)
- Wence Wang
National Key Research and Development Program (2021YFD1300404)
- Wence Wang
National Key Research and Development Program (2022YFD1300400)
- Wence Wang
National Key Research and Development Program (2022YFD1301800)
- Wence Wang
The funders had no role in study design, data collection, and interpretation, or the decision to submit the work for publication.
Acknowledgements
This study was sponsored by the National Science Fund for Outstanding Young Scholars (32222080), Guangdong Province Natural Science Funds for Distinguished Young Scholar (2022B1515020016), National Science Fund Project of China (32072751), National Key Research Program (2023YFD1301000, 2021YFD1300404, 2022YFD1300400, 2022YFD1301800), Guangdong Basic and Applied Basic Research Foundation (2022B1515130003), Guangdong Chimelong Philanthropic Foundation (CLPF2021007Z), and China Agriculture Research System (CARS-42-15).
Ethics
All animal procedures were approved by the Animal Experimentation Ethics Committee of the South China Agricultural University (SYXK-2019-0136).
Copyright
© 2024, Fu et al.
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 1
- views
-
- 0
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Microbiology and Infectious Disease
Deeper understanding of the crosstalk between host cells and Mycobacterium tuberculosis (Mtb) provides crucial guidelines for the rational design of novel intervention strategies against tuberculosis (TB). Mycobacteria possess a unique complex cell wall with arabinogalactan (AG) as a critical component. AG has been identified as a virulence factor of Mtb which is recognized by host galectin-9. Here, we demonstrate that galectin-9 directly inhibited mycobacterial growth through AG-binding property of carbohydrate-recognition domain 2. Furthermore, IgG antibodies with AG specificity were detected in the serum of TB patients. Based on the interaction between galectin-9 and AG, we developed a monoclonal antibody (mAb) screening assay and identified AG-specific mAbs which profoundly inhibit Mtb growth. Mechanistically, proteomic profiling and morphological characterizations revealed that AG-specific mAbs regulate AG biosynthesis, thereby inducing cell wall swelling. Thus, direct AG-binding by galectin-9 or antibodies contributes to protection against TB. Our findings pave the way for the rational design of novel immunotherapeutic strategies for TB control.
-
- Immunology and Inflammation
- Microbiology and Infectious Disease
Mortality and morbidity from tuberculous meningitis (TBM) are common, primarily due to inflammatory response to Mycobacterium tuberculosis infection, yet the underlying mechanisms remain poorly understood. We aimed to uncover genes and pathways associated with TBM pathogenesis and mortality, and determine the best predictors of death, utilizing whole-blood RNA sequencing from 281 Vietnamese adults with TBM, 295 pulmonary tuberculosis (PTB), and 30 healthy controls. Through weighted gene co-expression network analysis, we identified hub genes and pathways linked to TBM severity and mortality, with a consensus analysis revealing distinct patterns between HIV-positive and HIV-negative individuals. We employed multivariate elastic-net Cox regression to select candidate predictors of death, then logistic regression and internal bootstrap validation to choose best predictors. Increased neutrophil activation and decreased T and B cell activation pathways were associated with TBM mortality. Among HIV-positive individuals, mortality associated with increased angiogenesis, while HIV-negative individuals exhibited elevated TNF signaling and impaired extracellular matrix organization. Four hub genes—MCEMP1, NELL2, ZNF354C, and CD4—were strong TBM mortality predictors. These findings indicate that TBM induces a systemic inflammatory response similar to PTB, highlighting critical genes and pathways related to death, offering insights for potential therapeutic targets alongside a novel four-gene biomarker for predicting outcomes.